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ABSTRACT 
We lavestipted tbe metbanism by wbicb retinoic add causes growtb 
arrest aad O.t revenioa or SSV -NRK, simian san:oma virus-transformed 
aormaJ nt lddaey cells. Nortbem aaalysls revealed tbat botb cbronic (7 
days) aad acute (6 b) retlaolc acid treatmeat or se1'1111Hdmulated SSV-
NRK cells c:aused a 6-fold decrease Ia c-/M mRNA Ievels. Ia additioa, 
auclear rua-oa experimeats sbowed tbat retinoic add regulated c-/M 
expressloa Ia SSV-NRK cells at tbe transcriptioaal Initiation Ievel. 
Attenuatioa of c-/M traucriptioa was equal ia botb retiaoic acid-treated 
aad coatrol cells. aad ao iaaeased c-/01 mRNA turaover was detected ia 
retlaolc acld-treated cells. Furtbermore, tbere was ao obsened cqe ia 
tbe c-/M mRNA Ievels after oaly 30 mia of redaoic add treatmeat. 
Suaettiaa tbat a metbaalsm lavolriag tbe iaterruptioa of tbe Signal 
tnasdacdoa mecbaaism at tbe membnae Ievei ls uaUkely. Becaase it 
bas beea sbowa tbat c-/M expressloa plays a plvotal role Ia mltogeaesis 
or qaiesceat Obroblasts, we coaclude tbat tbe redaolc acid-medlated 
dowa-replatioa of C·/M expression is a metbanism for growtb labibition 
Ia SSV-NRK cells. 
INTRODUCfiON 
ln 1925 it was initially observed in rats that vitamin A 
deficiency Ieads to squamous metaplasia of mucous membranes 
and hyperkeratosis of the skin (I). Since then, RA, 3 a physio-
logically active vitamin A derivative, has been shown to inhibit 
the proliferation of a broad range of transformed cell types (2-
4}, as weil as to induce benign (terminal) difTerentiation in a 
group of transformed cell lines, including F9 murine teratocar-
cinoma (5), SMS-KCNR human neuroblastoma (6), and HL-
60 human promyelocytic leukemia (7). The mechanism by 
which RA mediates its multiple efTects on transformed cells is 
not weil understood. 
RA has been shown to inhibit anchorage-independent growth 
of SSV -NRK, a rat fibroblast cell line transfonned by simian 
sarcoma virus (8). Autocrine Stimulation ofthese cells by p28ais, 
a homologue of platelet-derived growth factor encoded by v-sis, 
resulted in unregulated proliferation (9). Although constitutive 
expression of v-sis has been demonstrated to be essential for 
the transfonned state of the cells (I 0), RA has been shown to 
have no eß'ects on v-sis expression (8). Therefore, other mech-
anisms are probably involved in mediating the growth inhibition 
of the transformed cells by the retinoids. 
A cascade of events occurs following mitogenic Stimulation 
of fibroblasts by growth factors, leading eventually to cell divi-
sion. Betonging to a group of immediate-early genes, c-fos plays 
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a pivotal role in these events, allowing cells to pass from Go-G• 
to the S phase of the cell cycle ( II ). Mitogenic Stimulation of 
serum-starved fibroblasts by serum or growth factors such as 
platelet-derived growth factor is associated with a very rapid 
induction of c-fos ( 12, 13). When a plasmid expressing antisense 
c-fos RNA is introduced into such an experimental system to 
block c-fos expression, the cell division does not occur (14). 
Furthermore, transfonned cells expressing antisense c-fos 
undergo flat reversion suggestive of benign diß'erentiation of 
the neoplastic cells (15). We observed that RA also caused flat 
reversion of SSV -NRK cells. Therefore, we hypothesize that 
RA afTects the signal transduction pathway, in particular the 
expression of c-fos. In this paper, data will be presented showing 
down-regulation of c-fos transcription in serum-stimulated 
SSV -NRK cells by RA. 
MATERIALSAND METHODS 
Cell Culture. SSV-NRK cells (a gift from Dr. S. Aaronson) were 
grown in Dulbea:o's medium enriched with 10% heat-inactivated calf 
serum. For treatment of cells. a stock of 4 x 10_, M all-trtuu-RA 
(Sigma, St. Louis, MO) was prepared in I 00% etbanol, stored at - 2o·c. 
and diluted immediately before use. Ia control cultures, ethanol was 
added to a final concentration of 0.25%. Cycloheximide was added to 
SO ~tg/ml where indicated. Cell growth kinetics were measured in 
triplicate in 35-mm plates seeded witb 2 x I 0" cells/plate and cell 
aumber was counted daily with a hemocytometer. Routine tests for 
Mycopltuma by tbe Hoecbst staining method (16) were negative. 
RNA Extractioa. RNA was prepared by the method o,f Chirgwin et 
GJ. (17). Briefly, total cellular RNA was extracted from approximately 
107 SSV-NRK cells. Cells were lysed with 6.7 M guanidine isothio-
cyanate (Research Organics, Cleveland, OH) in' the presence of I mM 
vanadyl ribonucleoside complex (Bethesda Research Laboratory, Gaith-
ersburg, MD), a RNase inhibitor. The lysate was centrifuged over a 
cushion of 3.5 M CsCI. The pelleted RNA was dissolved in water. 
Gel Electropboresis of RNA aad Nortbem Tnufer. Twenty ,ag de-
aatured total RNA was fractionated by electropboresis on agarose gel 
by using 10 mM NaHzPO• bufrer, pH 7.2 (18). An RNA ladder 
(Bethesda Research Laboratory) was included as size Standard. RNA 
was transferred to nylon membrane (Bio-Rad, Richmond, CA) by an 
alkaline transfer method of Vrati et 111. (19). After transferwas com-
pleted, the membranewas rinsed in 2 x SSC (I x SSC is O.IS M NaCI, 
0.015 M sodium citrate, pH 7.0) and 0.1% SDS and allowed to dry. lt 
was then baked at so·c ia a vacuum oven for I b. 
Hybrldizadoa. Prebybridization, hybridization, and washiaa were 
carried out under coaditions specified by Schleicher & Scbuell (Keene, 
NH). Prehybridizatioa and hybridization were carried out in solutions 
consisting of S x Deahardt's solution ( 1 x Denbardt's solution is 0.02% 
Ficoll, 0.02% polyvinylpyrrolidone, 0.02% bovine serum albumin), SO% 
formamide, 0.1% SDS, S X SSPE (I X SSPE is 0.18 M NaCI, 0.01 M 
NaPO., pH 7 .6, l mM EDTA), and 250 ,ag/ml denatured herring sperm 
DNA at 4rC for 6-24 h and 24-36 b, respectively. v-su, v-fos, c-myc 
(Oncor, Gaithersburg, MD), and c-jun (20) probes as weil as rat c:r7 
tubulin (21) were labeled witb (c:rn-P)dCTP (ICN, lrvine, CA) by the 
oligolabeling metbod (Pbarmac:ia Laboratories. Pisc:ataway, NJ) to at 
least l x I~ cpm/,.g DNA. After hybridization, the filten were washed 
sequentially in 6 x SSPE and O.S% SDS at room temperature for I S 
min twice, in I x SSPE and 0.5% SOS at 37"C twice for 1 S min, and 
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in the latter solution at 65·c for 45 min. The filters were then exposed 
to X-ray film, usingau intensifying screen at -1o·c. 
Nadear Ran-On Transcrlptioa. Run-on transcripnon was carried out 
as desc:ribed by Mah~au aud Thompson (22) with modifications. Nuclei 
were prepared from approximately 107 ceUs, aud in vitro transcripnon 
was initiated by adding to 10 "I nuclear Suspension a 1 00-"1 mixture of 
0.5 M Tris-CI, pH 7 .8, 0.25 M NaCI, 1.75 M (NIL)2SO .. , 0.01 M EDTA, 
0.2 M MnCh, 1 ma/ml heparin, aud 100 I'M each of ribonuc:leoside 
triphosphates containing 100 "Ci (a-32P)UTP (Du Pont NEN, Wil-
minaton, DE) at 3rC. After inc:ubation for 45 min, RNA was extracted 
with phenol/chloroform, aud ethauol precipitated. Nuclear equivalents 
of labeled RNA from control aud RA-treated cells were hybridized to 
M 13 DNA probes containing eitber exon I or exons 3 aud 4 of murine 
c-/M (23) that were immobilized on nitroceUulose filters by using the 
slot-blot apparatus (Schleicher & Schuell). Plasmid pThl (kindly pro-
vided by Dr. E. A. Thompson), which encodes 5S RNA, was used as 
positive control. Prehybridization aud hybridization were carried out 
in a buffer containing 0.01 M NaCI, Denhardt's solution, aud 100 1'11 
ml polyadenylic acid at 65·c for 2 and 40 h, respectively. Filters were 
washed sequentially with 2 x SSC at 65·c for 1 h, 2 x SSC c:ontaining 
10 1'1/ml RNase A (Boehringer Maunheim, lndiauapolis, IN) at 37•c 
for 30 min, aud 2 x SSC at 37•c for 1 h. The r.Jters were then exposed 
to X-ray film as described above. 
Materials. Ultrapure c:esium chloride was from Bethesda Research 
Laboratories. Agarose (Seakem LE) was supplied by FMC BioProducts 
(Rockland, ME). Polyadenylic acid was purchased from Boehringer 
Mann heim. Actinomycin D aud cycloheximide were supplied by Merck 
Sharp & Dohme (West Point, PA) aud Sigma, respectively. All other 
reagents were of the higbest grade available aud were purchased from 
staudard sourc:es. 
RESULTS 
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Fig. 1. Northem blot analysis of c.j'os (A) and v-su (B) mRNA in RA·treated 
SSV-NRK c:ells. 1be cells were lfOWD to conßuence, serum starved, and serum 
stimulated u described in the text. Cells were treated with 10"' M RA (l.IJM I) 
or untreated (IAiw 1). 1be sizes of c.j'os and NU mRNA are 2.2 and 2. 7 kilobases 
(kb), respectively. 1be same blots were stripped and rehybridiud with a tubulin 
probe. 
v-sis transcription in SSV -transformed fibroblasts, as previously 
Effects of RA on CeU Growth. SSV-NRK cells (7.5 X 10") reported (8). 
were grown on duplicate 60-mm Petri dishes in a series of Half-Life of c-fos mRNA iD RA-treated CeUs. Since RA may 
dilutions of RA. The growth of these cells was inhibited by RA down-regulate the c-fos mRNA Ievels by increasing its degra-
in a dose-dependent manner: 85% of controls at 10_, M RA, dation, we performed actinomycin D experiments to measure 
70% at 10-6 M RA, and 60% at to-s M RA. Morphological the rate of c-fos mRNA decay. SSV-NRK cells were grown to 
changes suggestive of ßat reversion were also observed in all conßuence, serum starved, and serum induced as described 
RA-treated cultures, as early as 24 h in 1 o-s M RA. Our results above. Jmmediately following a 30-min period of serum induc-
agree with published data that anchorage-dependent growth of tion, actinomycin D at 30 ~o&g/ml was added. The cells were 
SSV-NRK cells was inhibited by RA at the median effective harvested at the time of actinomycin D addition and at 15-min 
dose of 5 x 10-6 M (8). intervals thereafter. RA was added 6 h before actinomycin D 
Effects of RA on c-/DI Expression. The expression of c-fos and maintained in the cultures until harvesting. The decay of 
has been reported to be one of the earliest responses in fibro- c-fos mRNA in the control was very rapid (Fig. 2), with a half-
blasts after mitogenic stimulation (13). We assayed c-fos mRNA life of 12 min, which is in agreement with previous reports (24, 
in response to serum stimulation in RA-treated cells. Cells were 25). The half-life of c-fos mRNA in RA-treated cells was esti-
grown to conßuence and serum starved by maintenance in 0.5% mated to be 17.5 min. The low Ievel expression of c-fos in the 
FBS for 48 h. During this time, they divided extremely slowly dnig-treated cells makes the half-life estimate rather inaccurate. 
(probably in response to constitutively expressing p28•). RA Jt is clear, however, that based on two independent experiments, 
at 10-s M was then added to the cultures for 6 h before the c-fos mRNA decay in RA-treated cells was not accelerated. 
harvesting for RNA extraction. Mitogenic Stimulation was Thus, RA does not appear to down-regulate the serum-induced 
achieved by incubating the cells in 20% FBS during the last 30 c-fos mRNA Ievel by increasing its turnover. 
min of RA treatment. Tbe Northem blots revealed a significant c-fos Transcripdon Initiation and Elongation. An alternative 
decrease in the steady-state Ievel of c-fos mRNA in treated cells site of action of RA in down-regulating c-fos expression is at 
(Fig. lA, LIJne 1) relative to the untreated control cells (Fig. the Ievel of transcription initiation and elongation. Therefore, 
lA, LIJne 2). Densitometric measurements determined the we performed nuclear run-on experiments. SSV -NRK cells were 
amount of c-fos mRNA in RA-treated cells tobe one-fourth grown to conßuence in 10% FBS, serum starved for 48 h, and 
that in the untreated controls, as normalized against tubulin serum induced for 30 min with 20% FBS. Cells were grown in 
bands. The experiment was repeated four times, giving an the presence of 1 o-s M RA for 7 h before harvesting. Fig. 3 
average 6-fold reduction of c-fos expression. Chronic (1 week) shows that the transcripnon of the fii'St exon of c-/os in RA-
exposure of SSV-NRK cells to 10-6 RA resulted in a similar treated cells was much reduced. From densitometric analyses, 
decrease in c-fos mRNA Ievels (data not shown). RA also the intensity of the band corresponding to the fli'St exon is 
bloc:ked the induction of two other serum-inducible nuclear decreased 4-fold in RA-treated cells as compared to control 
oncogenes, c-jun and, to a lesser extent, c-myc (data not shown). cells (after correcting for small difJerences in the 5S RNA-
Our data (Fig. IB) further confirmed that RA did not inhibit positive controls). The difference between RA-treated and con-
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Fis. 2. Determination ofthe half-life of c-fos mRNA. Conßuent., serum-starved 
cells were exposed to lo-s M RA 5.5 h prior to serum stimulation. Twenty % 
FBS containins RA was then added and 30 min later 30 .,g!ml actinomydn D 
was added. Cells were harvested at time 0, i.e., the time of actinomycin addition 
(ÜIIIt I), and at 15-min intervals thereafter (ÜIIIts 1, J, 4, and S). RNA was 
extracted and analyzed by Northem hybridization techniques. The 2.2-kilobase 
(kb) band is the c-/01 mRNA. +RA, with RA treatment; ~RA, without RA 
treatment. tub, tubulin. 
-RA +RA 
1 
2 
3 
4 
5 
Fis. 3. Nuclear run-on analysis of c-/01 transc:ription. SSV-NRK cells were 
serum saarved and serum stimulated as described in text. RA (lo-s M) was added 
to the culture 6.5 h before serum Stimulation and the cells were maintained in 
20% FBS for 30 min until harvestins. The nuclear run-on experiments were 
perfonned as described in "Materials and Methods." DNA blotted on the mem-
brane was for detectins: Slot I, 5S RNA; Slot 1, the sense transcript.of the c-fos 
gene exon I; Slot J, the antisense transcript of exon I; Slot 4, the antisense 
transc:ript of exons 3 and 4; and Slot S, the sense transc:ript of exons 3 and 4. 
+RA, with RA treatment; -RA, without RA treatment. 
cells, meaning that RA does not affect the rate of elongation. 
Effect of Cycloheximide. Cycloheximide, an inhibitor of pro-
tein synthesis, has been shown to increase the Ievei of c-fos 
mRNA in quiescent 3T3 cells and also their serum-induced 
Ievel ( 13). Termed superinduction, this phenomenon has been 
explained on the basis of the inhibition by the drug of the 
synthesis of a labile nuclease that degrades mRNA or of the 
contact between the mRNA and a ribosome-associated nuclease 
(24). We tested the efTect of RA on the cycloheximide-super-
induced c-fos mRNA Ievels. SSV -NRK cells were starved and 
serum stimulated as before. Cycloheximide, SO 1'8/ml, was 
added 3 h prior to serum Stimulation. As shown in Fig. 4, 
cycloheximide treatment resulted in a 3-fold increase in the c-
fos mRNA Ievel (Lilne 3). RA blocked c-fos induction by serum 
in the presence of cycloheximide (Lilne 4), consistent with the 
notion that RA acts at the Ievel of transcription initiation, 
whereas the effect of cycloheximide is at the Ievel of mRNA 
turnover. 
Does RA Regulate c-/o! mRNA Level by Directly Interfering 
with a Membrane Sigoal Transduction Mechanism? The mech-
anism of action of RA at the molecular Ievel is not fully 
understood. Earlier models for retinoid action proposed the 
involvement of both calcium-cyclic AMP and phosphatidyl 
inositol membrane signal transduction pathways (26-28). The 
induction of c-fos in fibroblasts following the Stimulation by 
growth factor is very rapid, usually within S min, reaching a 
steady-state Ievel in about 30 min (12, 13). To test whether RA 
interferes with. the signal transduction pathway at the mem-
brane Ievel, we examined the response of c-fos expression to 
short-term RA treatment. SSV-NRK cells were grown in 10% 
FBS and starved in O.S% FBS for 2 days. RA was added to the 
serum-starved cultures to a final concentration of I o-s M S min 
before addition of 20% FBS. This would ensure that RA could 
take efTect before the phosphatidyl inositol cascade would be 
activated by serum (in a matter ofseconds) (12). The cells were 
then incubated for an additional 2S min before harvesting. The 
results demonstrated that a 30-min exposure to RA was insuf-
ficient to cause a decrease in c-fos mRNA Ievels in SSV-NRK 
cells (Fig. S). A most likely explanation for this observation is 
that RA, a lipid-soluble substance, does not directly interfere 
with the initial phase of signal transduction pathway. 
1 2 3 4 
RA + + 
CH + + 
trol cells in the intensities of the bands corresponding to the 
further downstream third and fourth exons is also about 4-fold, 
indicating that transcription elongation does not appear to be 
afTected by RA. We conclude therefore that the major efTect of 2.2 kb -
RA on c-fos mRNA transcription is its inhibition of transcrip-
tion initiation. 
It was noted here and by others (25) that transcription of c-
fos mRNA is apparently attenuated. The ratio of signals for the 
first exon and to that for the third and fourth exons is 2.5 in Fig. 4. Cycloheximide does not bloc:k the RA effec:l on c-/01 induc:lion. The 
fi . • f SSV -NRK cells were slarved and serum stimulated as before. RA and cyclohex-untreated cells, after adjusting or slight differences m Slze O imide were added 6 and 3 h before serum stimulation, respectively; 2.2 kilobases 
the probes. The attenuation is similarly observed in RA-treated (kb) indicates the size of c-fos mRNA. CH, cycloheximide. 
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1 2 
2.2 kb-
v als 
Fia. 5. Lack of effect on c-fos expression in cells treated with RA for only 30 
min. The SSV-NRK cells were starved and serum stimulated as before. RA, w-s 
M, was added 5 min before serum stimulation. Cells were harvested 25 min after 
the addition of 20% fetal bovine serum containing RA for RNA extraction. lAne 
I, with RA, and lAne 2, without RA treatment; 2.2 kilobases (kb) indicates the 
c-fos mRNA band. The same blot was stripped and rehybridized with the v-sis 
probe. 
DISCUSSION 
elements through other protein factors. 
RAR a, ß, and 'Y belong to the steroid/thyroid hormone/ 
retinoic acid receptor superfamily (36, 37). The receptors, upon 
binding to the ligands, recognize specific sequences that are 
localized upstream from a target gene, resulting in activation 
(or repression) ofthat gene. A RAR-binding sequence has been 
identified as a direct repeat of the motif GTICAC (38). A 
simple explanation of our results is that the RAR binds to the 
retinoic acid response element near SRE. In support of this 
notion, Schüle et al. reported that AP-1 and RAR recognize a 
common response element in the human osteocalcin gene (39). 
However, a ·search for the RAR-binding sequence within ap-
proximately 280 base pairs 5' and 3' of SRE in the murine c-
fos gene (available in GENBANK) has been unsuccessful. lt is 
more likely then that RAR interacts with SRF or other trans-
activating factors that regulate c-fos expression. This possibility 
was raised by recent reports that negative regulation of genes 
by the glucocorticoid hormone could occur via protein-protein 
interaction between c-Jun and the hormone receptor (40, 41). 
In the HL-60 human promyelocytic cell line differentiating 
into granulocytes, c-fos expression has been shown to be up-
regulated by RA (42), and this up-regulation appears to play a 
roJe in their differentiation. c-fos up-regulation is also reported 
for differentiating F9 murine teratocarcinoma cells (43). In a 
human embryonal carcinoma cellline, NT2/D 1, RA has mini-
mal effects on c-fos expression (44). To our knowledge, ours is 
the first case where c-fos expression is down-regulated by RA 
in a cellline. The finding may be important in explaining some 
of the antitumor effects of RA. 
ACKNOWLEDGMENTS 
We thank Dr. S. Aaronson for SSV-NRK cells; Dr. I. Verma for a 
c-jun plasmid, pcD I 0; Dr. E. A. Thompson for assistance in the nuclear 
run-on· experiments and critical review of the manuscript; and On. T. 
Sato and I. Boldogh for advice. 
Data presented in this paper demoostrate that RA blocks the 
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